Immediate Management of Intracranial Hemorrhage
The immediate management of intracranial hemorrhage requires rapid assessment and reversal of coagulopathy (if present), blood pressure control, neurological monitoring, and urgent neurosurgical consultation for potentially life-threatening lesions. 1
Initial Assessment and Stabilization
Airway, Breathing, Circulation
Urgent Neurological Evaluation
- Assess pupils and GCS motor score
- Obtain immediate brain CT scan 1
- Determine severity and type of hemorrhage
Reversal of Anticoagulation
Immediate reversal of anticoagulation is critical to prevent hematoma expansion:
Vitamin K Antagonists (e.g., Warfarin)
- Administer vitamin K 10 mg IV plus prothrombin complex concentrate (PCC) 1
- PCC dosing based on weight and INR
- If PCC unavailable, use fresh frozen plasma (10-15 mL/kg) 1
- Target INR ≤1.4, preferably ≤1.2 2
- Monitor INR at 15-60 minutes post-administration and every 6-8 hours for 24-48 hours 1
Direct Oral Anticoagulants (DOACs)
- For dabigatran: Administer idarucizumab 5g IV (if within 3-5 half-lives or renal impairment) 1
- For factor Xa inhibitors: Administer 4-factor PCC (50 U/kg) or aPCC (50 U/kg) 1
- Consider activated charcoal (50g) if ingestion within 2 hours 1
Heparin/LMWH
- For unfractionated heparin: Administer protamine sulfate (1 mg per 100 units of heparin given in previous 2-3 hours, max 50 mg) 1
- For LMWH: Administer protamine (1 mg per 1 mg enoxaparin or 100 anti-Xa units of other LMWH) 1
Antiplatelet Agents
- Discontinue all antiplatelet agents immediately 1
- No specific reversal agents are routinely recommended
Blood Pressure Management
- Maintain SBP <160 mmHg while ensuring adequate cerebral perfusion
- For patients requiring emergency surgery, maintain SBP >100 mmHg or MAP >80 mmHg 1
- In cases of cerebral herniation, more aggressive BP control may be needed
Coagulation Management
- Maintain platelet count >50,000/mm³ (higher for neurosurgical interventions) 1
- Maintain PT/aPTT <1.5 times normal for emergency neurosurgery 1
- Consider point-of-care coagulation testing if available 1
Neurosurgical Consultation
- Urgent neurosurgical consultation for:
Additional Management
- For subarachnoid hemorrhage from aneurysm: Consider nimodipine 60 mg orally every 4 hours for 21 days 3
- Seizure management: No prophylactic anticonvulsants recommended routinely 1
- Avoid statin therapy specifically for ICH prevention 1
- Avoid recombinant Factor VIIa outside clinical trials 1
Monitoring
- Frequent neurological assessments
- Consider ICP monitoring for patients at risk for intracranial hypertension 1
- Repeat brain imaging if neurological deterioration occurs
Timing of Anticoagulation Resumption
- Decision to restart anticoagulation should be made on a case-by-case basis 1
- Generally safe to discontinue anticoagulation for 1-2 weeks in most patients 4, 5
- For patients with mechanical heart valves, temporary interruption appears safe 4
Common Pitfalls to Avoid
- Delaying reversal of anticoagulation while waiting for coagulation test results
- Inadequate blood pressure control
- Failure to recognize expanding hematoma requiring surgical intervention
- Premature resumption of anticoagulation
- Overlooking underlying vascular abnormalities (aneurysms, AVMs) that may require specific treatment 6
By following this structured approach, the immediate management of intracranial hemorrhage can be optimized to reduce morbidity and mortality.